Octagon Capital Advisors LP Mirum Pharmaceuticals, Inc. Transaction History
Octagon Capital Advisors LP
- $449 Million
- Q4 2024
Shares
2 transactions
Others Institutions Holding MIRM
# of Institutions
208Shares Held
54MCall Options Held
64.1KPut Options Held
117K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.57MShares$329 Million13.79% of portfolio
-
Janus Henderson Group PLC London, X04.58MShares$229 Million0.1% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$162 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA2.8MShares$140 Million4.33% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.61MShares$130 Million2.07% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.84B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...